Skip to content

Clinical trials

Terminated Hematologic Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Diseases Status: Terminated Country / region: United States Clear all

47 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20021
20031
20041
20051
20062
20072
20082
20104
20111
20121
20132
20145
20152
20162
20174
20183
20192
20202
20211
20221
20233
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated47

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Seagen Inc.6
M.D. Anderson Cancer Center5
CTI BioPharma2
Celgene2
Emory University2
Fred Hutchinson Cancer Center2
Pfizer2
Shionogi2
Ariad Pharmaceuticals1
Baxalta now part of Shire1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Diseases47
Neoplasms8
Anemia, Sickle Cell7
Leukemia7
Lymphoma, Large B-Cell, Diffuse7
Bone Marrow Diseases6
Leukemia, Lymphocytic, Chronic, B-Cell6
Leukemia, Myeloid, Acute6
Lymphoma6
Lymphoma, Non-Hodgkin6

Trials

Showing 1 to 25 of 47. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.